title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
AbbVie  ( ABBV )  Announces Appointment of New CEO Robert Michael,20240221T154300,https://www.zacks.com/stock/news/2229455/abbvie-abbv-announces-appointment-of-new-ceo-robert-michael,PBYI,0.406745,Somewhat-Bullish,0.231943
Pfizer's  ( PFE )  Ulcerative Colitis Pill Velsipity Gets EU Nod,20240220T120900,https://www.zacks.com/stock/news/2228287/pfizers-pfe-ulcerative-colitis-pill-velsipity-gets-eu-nod,PBYI,0.354741,Somewhat-Bullish,0.193507
Stocks That Hit 52-Week Lows On Wednesday,20220511T162815,https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article,PBYI,0.006905,Neutral,0.007044
Stocks That Hit 52-Week Lows On Friday,20220506T160650,https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article,PBYI,0.005467,Neutral,0.000255
Annexon  ( ANNX )  Stock Rallies 156% in 3 Months: Here's How,20240117T160600,https://www.zacks.com/stock/news/2211545/annexon-annx-stock-rallies-156-in-3-months-heres-how,PBYI,0.220809,Somewhat-Bullish,0.161808
"Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday - Angel Oak Mortgage  ( NYSE:AOMR ) , Ampco-Pittsburgh  ( NYSE:AP ) ",20221128T100924,https://www.benzinga.com/news/22/11/29866518/why-richardson-electronics-shares-surged-over-8-here-are-55-biggest-movers-from-friday,PBYI,0.075161,Somewhat-Bearish,-0.304507
Assertio  ( ASRT )  Stock Plunges 65% in 3 Months: Here's Why,20240205T152400,https://www.zacks.com/stock/news/2221133/assertio-asrt-stock-plunges-65-in-3-months-heres-why,PBYI,0.386477,Somewhat-Bullish,0.223866
Assertio  ( ASRT )  Shares Fall as Dan Peisert Steps Down as CEO,20240104T144600,https://www.zacks.com/stock/news/2205675/assertio-asrt-shares-fall-as-dan-peisert-steps-down-as-ceo,PBYI,0.374875,Somewhat-Bullish,0.168052
Here's Why You Should Invest in Adverum  ( ADVM )  Stock Now,20240104T132700,https://www.zacks.com/stock/news/2205527/heres-why-you-should-invest-in-adverum-advm-stock-now,PBYI,0.209365,Neutral,0.058665
Here's Why You Should Bet on Rigel Pharmaceuticals  ( RIGL )  Now,20240103T155100,https://www.zacks.com/stock/news/2205099/heres-why-you-should-bet-on-rigel-pharmaceuticals-rigl-now,PBYI,0.211806,Neutral,-0.00328
Here's Why You Should Invest in Aquestive  ( AQST )  Stock Now,20240103T131000,https://www.zacks.com/stock/news/2204853/heres-why-you-should-invest-in-aquestive-aqst-stock-now,PBYI,0.164656,Neutral,-0.002724
Syros  ( SYRS )  Rises on Upbeat Initial Study Data on Tamibarotene,20231207T144400,https://www.zacks.com/stock/news/2194793/syros-syrs-rises-on-upbeat-initial-study-data-on-tamibarotene,PBYI,0.332658,Somewhat-Bullish,0.172086
Journey Medical  ( DERM )  Up on Update for Skin Disease Candidate,20231207T141600,https://www.zacks.com/stock/news/2194715/journey-medical-derm-up-on-update-for-skin-disease-candidate,PBYI,0.229872,Neutral,0.089237
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,PBYI,0.043108,Neutral,0.0
EXEL: 3 Biotech Stocks Losing Momentum as March Ends,20230329T141736,https://stocknews.com/news/exel-mgnx-pbyi-incy-3-biotech-stocks-losing-momentum-as-march-ends/,PBYI,0.152499,Somewhat-Bullish,0.206921
"Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday - Alcoa  ( NYSE:AA ) , Adient  ( NYSE:ADNT ) ",20221107T080741,https://www.benzinga.com/news/22/11/29586663/why-mediaalpha-shares-jumped-around-30-here-are-112-biggest-movers-from-friday,PBYI,0.03443,Somewhat-Bullish,0.310813
"Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - ABVC BioPharma  ( NASDAQ:ABVC ) , Akumin  ( NASDAQ:AKU ) ",20230720T120402,https://www.benzinga.com/news/23/07/33301335/why-nanobiotix-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket,PBYI,0.169081,Somewhat-Bullish,0.334027
"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",20220804T130628,https://www.benzinga.com/general/biotech/22/08/28353376/biotech-daily-amgen-gilead-go-shopping-nod-for-astrazenecas-lynparza-in-early-stage-breast-cancer,PBYI,0.09989,Neutral,0.0
"Dr. Reddy's  ( RDY ) , COYA Ink Deal to Develop COYA 302 for ALS",20231207T125700,https://www.zacks.com/stock/news/2194626/dr-reddys-rdy-coya-ink-deal-to-develop-coya-302-for-als,PBYI,0.21258,Neutral,0.131373
AstraZeneca's  ( AZN )  sBLA for Enhertu Gets FDA's Priority Tag,20240130T124400,https://www.zacks.com/stock/news/2217677/astrazenecas-azn-sbla-for-enhertu-gets-fdas-priority-tag,PBYI,0.213517,Somewhat-Bullish,0.157631
Apellis  ( APLS )  Down on Negative CHMP Opinion for Pegcetacoplan,20240129T134800,https://www.zacks.com/stock/news/2216945/apellis-apls-down-on-negative-chmp-opinion-for-pegcetacoplan,PBYI,0.159218,Neutral,0.129027
SpringWorks  ( SWTX )  Surges More Than 80% in 3 Months: Here's Why,20240125T141900,https://www.zacks.com/stock/news/2215721/springworks-swtx-surges-more-than-80-in-3-months-heres-why,PBYI,0.335367,Somewhat-Bullish,0.199549
Heron  ( HRTX )  Gains 19% on FDA Nod for Zynrelef Label Expansion,20240125T114400,https://www.zacks.com/stock/news/2215517/heron-hrtx-gains-19-on-fda-nod-for-zynrelef-label-expansion,PBYI,0.222327,Somewhat-Bullish,0.162653
Travere  ( TVTX )  Stock Up More Than 30% in 3 Months: Here's Why,20240124T162500,https://www.zacks.com/stock/news/2215121/travere-tvtx-stock-up-more-than-30-in-3-months-heres-why,PBYI,0.302429,Somewhat-Bullish,0.184301
Here's Why Investors May Bet on BioMarin  ( BMRN )  Stock Now,20240124T162100,https://www.zacks.com/stock/news/2215118/heres-why-investors-may-bet-on-biomarin-bmrn-stock-now,PBYI,0.246832,Neutral,0.11459
Unicycive  ( UNCY )  Up on Positive Hyperphosphatemia Study Update,20240124T143900,https://www.zacks.com/stock/news/2214931/unicycive-uncy-up-on-positive-hyperphosphatemia-study-update,PBYI,0.217346,Somewhat-Bullish,0.159823
Lisata  ( LSTA )  Stock Up More Than 35% in 3 Months: Here's Why,20240123T171200,https://www.zacks.com/stock/news/2214420/lisata-lsta-stock-up-more-than-35-in-3-months-heres-why,PBYI,0.33628,Somewhat-Bullish,0.199957
Mirum  ( MIRM )  Banks on Livmarli Sales Despite Recent Setback,20240123T164400,https://www.zacks.com/stock/news/2214378/mirum-mirm-banks-on-livmarli-sales-despite-recent-setback,PBYI,0.259451,Somewhat-Bullish,0.163277
Alvotech  ( ALVO )  Up on BLA Update for Two Biosimilar Candidates,20240122T150300,https://www.zacks.com/stock/news/2213525/alvotech-alvo-up-on-bla-update-for-two-biosimilar-candidates,PBYI,0.371523,Somewhat-Bullish,0.230099
Mesoblast  ( MESO )  Up on Rare Pediatric Disease Tag for Heart Drug,20240119T163000,https://www.zacks.com/stock/news/2212927/mesoblast-meso-up-on-rare-pediatric-disease-tag-for-heart-drug,PBYI,0.361802,Somewhat-Bullish,0.211065
Syros  ( SYRS )  Stock Surges 200% in 3 Months: Here's Why,20240119T154300,https://www.zacks.com/stock/news/2212898/syros-syrs-stock-surges-200-in-3-months-heres-why,PBYI,0.341857,Somewhat-Bullish,0.202409
Instil  ( TIL )  Stock Rises More Than 20% in a Week: Here's Why,20240118T172800,https://www.zacks.com/stock/news/2212365/instil-til-stock-rises-more-than-20-in-a-week-heres-why,PBYI,0.401331,Somewhat-Bullish,0.22721
Is it a Good Idea to Invest in Intellia  ( NTLA )  Stock Now?,20240118T165000,https://www.zacks.com/stock/news/2212290/is-it-a-good-idea-to-invest-in-intellia-ntla-stock-now,PBYI,0.313218,Somewhat-Bullish,0.200468
Aclaris  ( ACRS )  Stock Rises on Appointment of New Interim CEO,20240117T161400,https://www.zacks.com/stock/news/2211548/aclaris-acrs-stock-rises-on-appointment-of-new-interim-ceo,PBYI,0.331765,Somewhat-Bullish,0.197928
Reasons to Add Blueprint  ( BPMC )  Stock to Your Portfolio Now,20240116T165100,https://www.zacks.com/stock/news/2210923/reasons-to-add-blueprint-bpmc-stock-to-your-portfolio-now,PBYI,0.262805,Somewhat-Bullish,0.164932
Solid Biosciences  ( SLDB )  Rises 271% in 3 Months: Here's Why,20240115T151800,https://www.zacks.com/stock/news/2210246/solid-biosciences-sldb-rises-271-in-3-months-heres-why,PBYI,0.367141,Somewhat-Bullish,0.225693
Amicus  ( FOLD )  Stock Rises More Than 25% in 3 Months: Here's Why,20240112T143100,https://www.zacks.com/stock/news/2209482/amicus-fold-stock-rises-more-than-25-in-3-months-heres-why,PBYI,0.322233,Somewhat-Bullish,0.150114
Bausch Health  ( BHC )  Ulcerative Colitis Drug Meets Primary Goal,20231222T152300,https://www.zacks.com/stock/news/2201653/bausch-health-bhc-ulcerative-colitis-drug-meets-primary-goal,PBYI,0.308504,Somewhat-Bullish,0.162382
Alterity  ( ATHE )  Up on Preclinical Parkinson's Treatment Data,20231205T181900,https://www.zacks.com/stock/news/2193796/alterity-athe-up-on-preclinical-parkinsons-treatment-data,PBYI,0.256989,Neutral,0.114272
Vanda  ( VNDA )  Rises as FDA Accepts NDA for Gastroparesis Drug,20231205T141700,https://www.zacks.com/stock/news/2193518/vanda-vnda-rises-as-fda-accepts-nda-for-gastroparesis-drug,PBYI,0.294446,Somewhat-Bullish,0.158774
Apellis  ( APLS )  Rides on Syfovre to Fuel Growth Amid Rivalry,20231204T154500,https://www.zacks.com/stock/news/2193043/apellis-apls-rides-on-syfovre-to-fuel-growth-amid-rivalry,PBYI,0.277748,Somewhat-Bullish,0.155752
AstraZeneca  ( AZN )  to Discontinue Two Studies on Lokelma,20231201T162700,https://www.zacks.com/stock/news/2192314/astrazeneca-azn-to-discontinue-two-studies-on-lokelma,PBYI,0.376005,Somewhat-Bullish,0.18837
AbbVie  ( ABBV )  Posts Encouraging Data From Lung Cancer Study,20231130T165600,https://www.zacks.com/stock/news/2191706/abbvie-abbv-posts-encouraging-data-from-lung-cancer-study,PBYI,0.236972,Neutral,0.133777
FDA Accepts Karuna's  ( KRTX )  NDA Filing for Schizophrenia Drug,20231130T165400,https://www.zacks.com/stock/news/2191704/fda-accepts-karunas-krtx-nda-filing-for-schizophrenia-drug,PBYI,0.199037,Neutral,0.093293
Adaptimmune  ( ADAP )  Rises as GSK Transfers T-Cell Therapy IND,20231130T155200,https://www.zacks.com/stock/news/2191582/adaptimmune-adap-rises-as-gsk-transfers-t-cell-therapy-ind,PBYI,0.380591,Somewhat-Bullish,0.202964
Emergent  ( EBS )  Gets $75M BARDA Contract for Anthrax Vaccine,20231129T165600,https://www.zacks.com/stock/news/2191044/emergent-ebs-gets-75m-barda-contract-for-anthrax-vaccine,PBYI,0.200273,Neutral,0.114046
Immunovant  ( IMVT )  Up on Positive Initial IMVT-1402 MAD Study Data,20231129T152200,https://www.zacks.com/stock/news/2190953/immunovant-imvt-up-on-positive-initial-imvt-1402-mad-study-data,PBYI,0.322233,Somewhat-Bullish,0.170252
SpringWorks  ( SWTX )  Rises on FDA Nod for Desmoid Tumor Drug,20231129T152000,https://www.zacks.com/stock/news/2190950/springworks-swtx-rises-on-fda-nod-for-desmoid-tumor-drug,PBYI,0.354572,Somewhat-Bullish,0.182946
Xenon  ( XENE )  Up on Top-Line Data From MDD Drug Phase II Study,20231128T161700,https://www.zacks.com/stock/news/2190420/xenon-xene-up-on-top-line-data-from-mdd-drug-phase-ii-study,PBYI,0.311631,Somewhat-Bullish,0.201505
TC BioPharm  ( TCBP )  Falls Despite FDA Clearing IND for AML Drug,20231128T160500,https://www.zacks.com/stock/news/2190409/tc-biopharm-tcbp-falls-despite-fda-clearing-ind-for-aml-drug,PBYI,0.359707,Somewhat-Bullish,0.224415
GSK's Blenrep Combo Meets PFS Endpoint in Head-to-Head Study,20231127T182200,https://www.zacks.com/stock/news/2189947/gsks-blenrep-combo-meets-pfs-endpoint-in-head-to-head-study,PBYI,0.261818,Neutral,0.083326
Freeline  ( FRLN )  Shares Rise on Merger Agreement With Syncona,20231123T160300,https://www.zacks.com/stock/news/2188517/freeline-frln-shares-rise-on-merger-agreement-with-syncona,PBYI,0.331765,Somewhat-Bullish,0.171736
"Immix  ( IMMX )  CAR-T Therapy IND Cleared by FDA, Stock Down",20231122T161000,https://www.zacks.com/stock/news/2187964/immix-immx-car-t-therapy-ind-cleared-by-fda-stock-down,PBYI,0.339046,Somewhat-Bullish,0.174543
Here's Why You May Invest in Puma Biotechnology  ( PBYI )  Stock,20231120T164700,https://www.zacks.com/stock/news/2186786/heres-why-you-may-invest-in-puma-biotechnology-pbyi-stock,PBYI,0.468029,Neutral,0.031328
"Earnings Scheduled For May 5, 2022",20220505T084322,https://www.benzinga.com/news/earnings/22/05/27012606/earnings-scheduled-for-may-5-2022,PBYI,0.009774,Neutral,-0.016303
Corcept  ( CORT )  Falls on Loss of Korlym Patent Lawsuit to Teva,20240102T162700,https://www.zacks.com/stock/news/2204522/corcept-cort-falls-on-loss-of-korlym-patent-lawsuit-to-teva,PBYI,0.395012,Somewhat-Bullish,0.285731
5 Biotech Stocks to Buy as Industry Prospects for 2H23 Look Good,20230613T133000,https://www.zacks.com/commentary/2107444/5-biotech-stocks-to-buy-as-industry-prospects-for-2h23-look-good,PBYI,0.092569,Neutral,0.016105
